{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:43Z","timestamp":1786980103560,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Orthop Trauma Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Optimal antibiotic prophylaxis for open fractures remains controversial, particularly regarding whether broader-spectrum regimens offer clinical advantages over cefazolin monotherapy. Despite guideline recommendations supporting first-generation cephalosporins for most open fractures, many centers routinely administer piperacillin-tazobactam. This study aims to evaluate differences in postoperative outcomes between cefazolin and piperacillin-tazobactam in lower extremity open fractures across all Gustilo-Anderson types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was performed using the TriNetX database to identify adult patients with Gustilo-Anderson type I-III lower extremity open fractures who received either cefazolin or piperacillin-tazobactam. 1:1 propensity score matching controlled for age, sex, demographics, and relevant comorbidities. Outcomes were assessed at 90 days and 1 year using risk ratios (RR) with corresponding 95% confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 47,692 patients met inclusion criteria prior to matching. After matching, 1,527 patients remained in each treatment group for the combined type I\/II\/III cohort and similar matched pairs were obtained for type I\/II and type III subgroups. At 90 days, cefazolin was associated with significantly lower rates of surgical site infection (RR 0.569), osteomyelitis (RR 0.292), sepsis (RR 0.244), reoperation (RR 0.474), readmission (RR 0.518), thromboembolic events (RR 0.480), AKI (0.448), and mortality (RR 0.208) across most analyses. Nonunion\/malunion rates were similar between groups for type I\/II and the combined cohort (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05), but higher among type III fractures treated with cefazolin (RR1.933). At 1 year, cefazolin was associated with significantly lower reoperation (RR 0.564), implant removal (RR 0.585), and mortality (RR 0.298) across all analyses, with persistently higher nonunion\/malunion risk in type III fractures (RR 1.929).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cefazolin was associated with comparable or superior outcomes to piperacillin-tazobactam for most postoperative complications following lower extremity open fractures. These findings support current guideline-aligned stewardship practices and question the routine use of broader-spectrum prophylaxis, particularly outside specific contamination scenarios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of evidence<\/jats:title>\n                    <jats:p>III \u2013 Retrospective Comparative Study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00402-026-06333-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:00:12Z","timestamp":1777453212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic prophylaxis for open lower extremity fractures: a comparative propensity-scored matched analysis of cefazolin vs. piperacillin-tazobactam"],"prefix":"10.1007","volume":"146","author":[{"given":"Kush S.","family":"Mody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish K.","family":"Ponna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Laychur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"6333_CR1","doi-asserted-by":"publisher","first-page":"102246","DOI":"10.1016\/j.jcot.2023.102246","volume":"44","author":"J Dheenadhayalan","year":"2023","unstructured":"Dheenadhayalan J, Nagashree V, Devendra A et al (2023) Management of open fractures: A narrative review. J Clin Orthop Trauma 44:102246. https:\/\/doi.org\/10.1016\/j.jcot.2023.102246","journal-title":"J Clin Orthop Trauma"},{"key":"6333_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00590-024-04141-z","volume":"35","author":"D Morgan","year":"2024","unstructured":"Morgan D, Lutnick E, Mutty C, Anders M (2024) Multidisciplinary standardized protocol decreases time to antibiotic administration for open fractures. Eur J Orthop Surg Traumatol Orthop Traumatol 35:23. https:\/\/doi.org\/10.1007\/s00590-024-04141-z","journal-title":"Eur J Orthop Surg Traumatol Orthop Traumatol"},{"key":"6333_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/BOT.0000000000002805","volume":"38","author":"E Heiman","year":"2024","unstructured":"Heiman E, Delaune J, Hong IS et al (2024) Maximizing Adherence and Minimizing Time to Antibiotics: A Multidisciplinary Institutional Trauma Bay Protocol for Single Antibiotic Prophylaxis in Open Fractures. J Orthop Trauma 38:313\u2013319. https:\/\/doi.org\/10.1097\/BOT.0000000000002805","journal-title":"J Orthop Trauma"},{"key":"6333_CR4","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1007\/s11999-012-2376-6","volume":"470","author":"PH Kim","year":"2012","unstructured":"Kim PH, Leopold SS (2012) In brief: Gustilo-Anderson classification. [corrected]. Clin Orthop 470:3270\u20133274. https:\/\/doi.org\/10.1007\/s11999-012-2376-6","journal-title":"Clin Orthop"},{"key":"6333_CR5","volume-title":"Prevention of surgical site infections after major extremity trauma: evidence-based clinical practice guideline","author":"American Academy of Orthopaedic Surgeons","year":"2022","unstructured":"American Academy of Orthopaedic Surgeons (2022) Prevention of Surgical Site Infections After Major Extremity Trauma: Evidence-Based Clinical Practice Guideline. American Academy of Orthopaedic Surgeons (AAOS), Rosemont, IL"},{"key":"6333_CR6","doi-asserted-by":"publisher","first-page":"e001304","DOI":"10.1136\/tsaco-2023-001304","volume":"9","author":"RD Appelbaum","year":"2024","unstructured":"Appelbaum RD, Farrell MS, Gelbard RB et al (2024) Antibiotic prophylaxis in injury: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surg Acute Care Open 9:e001304. https:\/\/doi.org\/10.1136\/tsaco-2023-001304","journal-title":"Trauma Surg Acute Care Open"},{"key":"6333_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/sur.2021.122","volume":"23","author":"CR O\u2019Connell","year":"2022","unstructured":"O\u2019Connell CR, Kooda KJ, Sawyer MD et al (2022) Evaluation of Piperacillin-Tazobactam for Antibiotic Prophylaxis in Traumatic Grade III Open Fractures. Surg Infect 23:41\u201346. https:\/\/doi.org\/10.1089\/sur.2021.122","journal-title":"Surg Infect"},{"key":"6333_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamasurg.2024.0429","volume":"159","author":"DR Long","year":"2024","unstructured":"Long DR, Cifu A, Salipante SJ et al (2024) Preventing Surgical Site Infections in the Era of Escalating Antibiotic Resistance and Antibiotic Stewardship. JAMA Surg 159:949\u2013956. https:\/\/doi.org\/10.1001\/jamasurg.2024.0429","journal-title":"JAMA Surg"},{"key":"6333_CR9","doi-asserted-by":"publisher","first-page":"e90890","DOI":"10.7759\/cureus.90890","volume":"17","author":"A Paterno","year":"2025","unstructured":"Paterno A, Nash A, Lauck B et al (2025) A Comparison of Piperacillin-Tazobactam With Conventional Antibiotics for Prophylaxis in Lower Extremity Type III. Open Fractures Cureus 17:e90890. https:\/\/doi.org\/10.7759\/cureus.90890","journal-title":"Open Fractures Cureus"},{"key":"6333_CR10","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1097\/MJT.0000000000001121","volume":"28","author":"AE Patanwala","year":"2019","unstructured":"Patanwala AE, Radosevich JJ, Meshay I et al (2019) Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures. Am J Ther 28:e284\u2013e291. https:\/\/doi.org\/10.1097\/MJT.0000000000001121","journal-title":"Am J Ther"},{"key":"6333_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2106\/JBJS.24.01123","volume":"107","author":"CA Lin","year":"2025","unstructured":"Lin CA, Kobes T, Kholodovsky E et al (2025) Outcomes Associated with Choice of Prophylactic Antibiotics in Open Fractures. J Bone Joint Surg Am 107:19\u201327. https:\/\/doi.org\/10.2106\/JBJS.24.01123","journal-title":"J Bone Joint Surg Am"},{"key":"6333_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","volume":"17","author":"T-L Nguyen","year":"2017","unstructured":"Nguyen T-L, Collins GS, Spence J et al (2017) Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol 17:78. https:\/\/doi.org\/10.1186\/s12874-017-0338-0","journal-title":"BMC Med Res Methodol"},{"key":"6333_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70198","author":"E Stein","year":"2025","unstructured":"Stein E, H\u00fcser M, Amirian ES et al (2025) Pharmacoepidemiol Drug Saf 34:e70198. https:\/\/doi.org\/10.1002\/pds.70198. TriNetX Dataworks-USA: Overview of a Multi-Purpose, De-Identified, Federated Electronic Health Record Real-World Data and Analytics Network and Comparison to the US Census"},{"key":"6333_CR14","volume-title":"Orthopedic and podiatry perioperative antibiotics","author":"D Hayward","year":"2025","unstructured":"Hayward D, Nammour MA (2025) Orthopedic and Podiatry Perioperative Antibiotics. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"6333_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/CORR.0000000000002808","volume":"482","author":"TJ Bates","year":"2024","unstructured":"Bates TJ, Burgess MB, Garcia GR et al (2024) Intravenous Cefazolin Achieves Sustained High Interstitial Concentrations in Open Lower Extremity Fractures. Clin Orthop 482:375\u2013383. https:\/\/doi.org\/10.1097\/CORR.0000000000002808","journal-title":"Clin Orthop"},{"key":"6333_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","volume":"57","author":"CM Perry","year":"1999","unstructured":"Perry CM, Markham A (1999) Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 57:805\u2013843. https:\/\/doi.org\/10.2165\/00003495-199957050-00017","journal-title":"Drugs"},{"key":"6333_CR17","doi-asserted-by":"publisher","first-page":"ofz270","DOI":"10.1093\/ofid\/ofz270","volume":"6","author":"M Beganovic","year":"2019","unstructured":"Beganovic M, Cusumano JA, Lopes V et al (2019) Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin\/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection. Open Forum Infect Dis 6:ofz270. https:\/\/doi.org\/10.1093\/ofid\/ofz270","journal-title":"Open Forum Infect Dis"},{"key":"6333_CR18","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA et al (2024) Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. https:\/\/doi.org\/10.1093\/cid\/ciae403. Clin Infect Dis ciae403","DOI":"10.1093\/cid\/ciae403"},{"key":"6333_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/BOT.0000000000000488","volume":"30","author":"J Westgeest","year":"2016","unstructured":"Westgeest J, Weber D, Dulai SK et al (2016) Factors Associated With Development of Nonunion or Delayed Healing After an Open Long Bone Fracture: A Prospective Cohort Study of 736 Subjects. J Orthop Trauma 30:149\u2013155. https:\/\/doi.org\/10.1097\/BOT.0000000000000488","journal-title":"J Orthop Trauma"}],"container-title":["Archives of Orthopaedic and Trauma Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06333-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00402-026-06333-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06333-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:00:15Z","timestamp":1777453215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00402-026-06333-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6333"],"URL":"https:\/\/doi.org\/10.1007\/s00402-026-06333-0","relation":{"references":[{"id-type":"doi","id":"10.1002\/pds.70198","asserted-by":"subject"}]},"ISSN":["1434-3916"],"issn-type":[{"value":"1434-3916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"166"}}